Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Astellas Pharma Inc. (ALPMF.PK)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
1 new
News & PR
Market Currents
Buzz
Twitter: ALPMF.PK
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Theravance, Inc.: Wait to Buy on Dip
Penn Bioinvestor
•
Nov 26
•
4 Comments
NeurogesX: Next Stop, U.S. Market
EP Vantage
•
Nov 19
•
2 Comments
Big Pharma Willing to Pay for Biotech Innovation
The Burrill Report
•
Nov 15
•
Comment!
This Week in Biotech: More Treats than Tricks
The Burrill Report
•
Nov 01
•
1 Comment
Astellas' Current Setback Underscores Need for Pipeline Expansion
EP Vantage
•
Aug 13
•
Comment!
FDA Calendar: 2H09 Binary Event Trades
Mike Havrilla
•
Jul 27
•
3 Comments
More articles on ALPMF.PK »
Instablogs
Updated FDA, Clinical Trial Calendars: CRME, MRK, LLY, PRX
Thu April 9, 2009
•
Mike Havrilla
•
2 Comments
Write a post on ALPMF.PK
|
More Instablogs on ALPMF.PK »
Sentiment
What advice would you give to
ALPMF.PK?
119 characters left
What's your view of ALPMF.PK?
Make sure you include ALPMF.PK
140 characters left
|
Settings